Bio-era is pleased to announce the publication of a new report, analyzing recent and expected impacts of the advance and adoption of new gene sequencing and synthesis technologies and techniques, and their likely significance in three strategically important sectors of the US economy: energy, chemicals, and vaccines. The report:

• Assesses possible trajectories for the emergence, application, and diffusion of whole genome synthesis, genomic design, and related technologies, and the implications for selected sectors -- particularly energy, chemicals, and vaccine production -- of the U.S. economy over the coming twenty-year period.
  
  
• Articulates highly plausible alternative futures and their implications for selected industries and economic sectors utilizing common assumptions regarding technology development, government and regulatory policies, public acceptance, and industry practice.

To order the report, please click here and submit the completed form. We will send you the report immediately upon receipt of payment.

Key questions to be answered:

• How fast will gene sequencing and synthesis technologies progress?
• What will be the future cost of gene sequencing and genome synthesis?
• What will be the most attractive and profitable applications?
• How could a successful open-source synthetic biology movement affect the future of the biotechnology industry?
• What does it mean to be able to "design" genomes from scratch?
• How will primary sectors of the economy -- energy, agriculture, chemicals, and pharmaceuticals -- be affected by the emergence of a genomic design discipline?
• What are some of the most significant biosecurity risks and how can they best be managed?

Who will benefit from this research?

• Marketing and business development executives from gene sequencing and synthesis technology companies
• Biotechnology and pharmaceutical companies that use gene sequencing and synthesis technologies
• Planning executives from energy, chemical, and vaccine industries interested in tracking how emerging technologies with disruptive and strategic importance will affect their industries in the years ahead
• Academic researchers and students active in the fields of gene sequencing, synthesis and synthetic biology
• Government policy makers, regulators and researchers from DOD, NSA, USDA, USDOE, FDA, EPA, Homeland Security and other federal agencies concerned with these emerging technologies

Contents:

1. Executive Summary

2. Enabling Technology: Advances in Biotech Tools and Approaches

2.1 Advances in sequencing and synthesis technologies
2.2 Genome engineering approaches
2.3 Challenges in genome design

3. Economic Dimensions of the Biological Engineering Revolution:
Invention, Innovation, Combination, and Diffusion

3.1 The Rise of Biological Engineering: More than Speed
3.2 How Quickly Can Synthetic Biology Advance?
3.3 The Power of Combination in Technological Systems
3.4 Directed Evolution
3.5 Economic Issues of Appropriability and Cumulativeness
3.6 The Makings of a Technology Revolution
3.7 Invention and Inn ovation: The Role of Technology Clusters
3.8 Diffusion Lags and Economic Impacts
3.9 Effects on Productivity
3.10 Biological Engineering and the Competitive Advantage of Nations
3.11 Conclusions and Implications

4. Applications of Genome Synthesis and Design

4.1 Chemicals: Engineering New Pathways and Creating New Products
4.2 Energy: Opening New Biological Routes for Energy Transformation
4.3 Synthetic Vaccines: Opportunities for Rapid-Response Biosecurity

5. Scenarios for the Future

5.1 The Scenario Elements
5.2 Overview of the Scenarios
5.3 Underworld - The New Era of Prohibition
5.4 The Gilded Lab - Slow but Steady Progress
5.5 Modular Life - The Genovation Explosion
5.6 Barricades - The New Manhattan Project

Excerpt from the Executive Summary

"Whether from the ground up or using snap together parts, whether proprietary or open source, genome synthesis will completely alter the economics of innovative biological design. Labor costs are decreasing rapidly while productivity is rising. New technologies will enable broad-based genetic design, and eventually, the fabrication of materials and structures locally at low cost. This is the beginning of “distributed biological manufacturing" – a new paradigm of materials production which should eventually be both less expensive and more efficient than traditional manufacturing processes in many industries."

Graphics

Metrics of Biotechnological Progress - Click here to download high-resolution graphics.

Sample:

Click here to enroll or get more info.

top